Javascript must be enabled to continue!
Abstract P407: Increased Secretion Of Glucose Dependent Insulinotropic Polypeptide Is Associated With Postprandial Hypotension In Patients With Parkinson Disease
View through CrossRef
Postprandial hypotension (PPH) is highly prevalent in Parkinson Disease (PD) and is defined as a sudden and substantial decrease (>20 mm Hg or >10 mm hg) in blood pressure within two hours after ingesting a meal. This condition is associated with syncope and falls. Eating a meal induces significant blood sequestration in the splanchnic circulation through the release of gastrointestinal (GI) hormones. Patients with autonomic dysfunction cannot compensate for these hemodynamic changes, which results in PPH. The purpose of this study is to evaluate if increased secretion of GI hormones, including glucose-dependent insulinotropic polypeptide (GIP), a strong splanchnic vasodilator, contributes to PPH in those with PD. We enrolled 11 PD patients, seven with PPH (PPH+) (age 69±7.65 years old, 72% males, Unified Parkinson’s Disease Rating Scale 29±18.9) and four without PPH (PPH-) (age 67±1.71 years, 75% males, UPDRS 20±15.30). PD PPH+ patients had evidence of autonomic impairment and orthostatic hypotension as defined by a change in systolic blood pressure, (-57±29.23 vs. -7±17.66 mm Hg in PPH). Blood pressure, heart rate, and blood GIP levels were measured before and at 5, 10, 15, 30, 60, 90, 120 min timepoints after 75 gr oral glucose in supine position. There was a time-dependent decrease in blood pressure with a nadir at 30 min (-17±14.30 mmHg vs. -5±17.26 in PPH-). In PD PPH+, peak GIP secretion also occurred at 30 min post-glucose ingestion (315.3±297.9 vs. 69.1±34.8 pmol/L in PPH-). PD PPH+ patients had a greater secretion of C-peptide (2141±1017.81 vs.1540.56±428.77 pmol/L in PPH-) and insulin (1477.78±1572.80 vs. 351.09±141.53 pmol/L in PPH-). These initial results show excessive GIP secretion in PD patients with PPH, suggesting that GIP may contribute to its pathophysiology.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract P407: Increased Secretion Of Glucose Dependent Insulinotropic Polypeptide Is Associated With Postprandial Hypotension In Patients With Parkinson Disease
Description:
Postprandial hypotension (PPH) is highly prevalent in Parkinson Disease (PD) and is defined as a sudden and substantial decrease (>20 mm Hg or >10 mm hg) in blood pressure within two hours after ingesting a meal.
This condition is associated with syncope and falls.
Eating a meal induces significant blood sequestration in the splanchnic circulation through the release of gastrointestinal (GI) hormones.
Patients with autonomic dysfunction cannot compensate for these hemodynamic changes, which results in PPH.
The purpose of this study is to evaluate if increased secretion of GI hormones, including glucose-dependent insulinotropic polypeptide (GIP), a strong splanchnic vasodilator, contributes to PPH in those with PD.
We enrolled 11 PD patients, seven with PPH (PPH+) (age 69±7.
65 years old, 72% males, Unified Parkinson’s Disease Rating Scale 29±18.
9) and four without PPH (PPH-) (age 67±1.
71 years, 75% males, UPDRS 20±15.
30).
PD PPH+ patients had evidence of autonomic impairment and orthostatic hypotension as defined by a change in systolic blood pressure, (-57±29.
23 vs.
-7±17.
66 mm Hg in PPH).
Blood pressure, heart rate, and blood GIP levels were measured before and at 5, 10, 15, 30, 60, 90, 120 min timepoints after 75 gr oral glucose in supine position.
There was a time-dependent decrease in blood pressure with a nadir at 30 min (-17±14.
30 mmHg vs.
-5±17.
26 in PPH-).
In PD PPH+, peak GIP secretion also occurred at 30 min post-glucose ingestion (315.
3±297.
9 vs.
69.
1±34.
8 pmol/L in PPH-).
PD PPH+ patients had a greater secretion of C-peptide (2141±1017.
81 vs.
1540.
56±428.
77 pmol/L in PPH-) and insulin (1477.
78±1572.
80 vs.
351.
09±141.
53 pmol/L in PPH-).
These initial results show excessive GIP secretion in PD patients with PPH, suggesting that GIP may contribute to its pathophysiology.
Related Results
Utility of home blood pressure monitoring to evaluate postprandial blood pressure in treated hypertensive patients
Utility of home blood pressure monitoring to evaluate postprandial blood pressure in treated hypertensive patients
Postprandial hypotension, defined as a fall in systolic blood pressure (SBP) of 20 mmHg or greater within 2 hours after a meal, is a risk factor for stroke, coronary events and mo...
Poloxamer 407 Based Gel Formulations for Transungual Delivery of Hydrophobic Drugs: Selection and Optimization of Potential Additives
Poloxamer 407 Based Gel Formulations for Transungual Delivery of Hydrophobic Drugs: Selection and Optimization of Potential Additives
The current study aimed to develop poloxamer 407 (P407) gel for transungual delivery of antifungal hydrophobic drugs with sufficient gel strength and drug loading. Gel strength and...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Effects of Different Proportion of Carbohydrate in Breakfast on Postprandial Glucose Excursion in Normal Glucose Tolerance and Impaired Glucose Regulation Subjects
Effects of Different Proportion of Carbohydrate in Breakfast on Postprandial Glucose Excursion in Normal Glucose Tolerance and Impaired Glucose Regulation Subjects
Background:
The variability of postprandial plasma glucose is an independent risk factor for diabetes. The type and amount of carbohydrate may be important dete...
Does eating a reheated starchy carbohydrate meal improve postprandial glycaemia?
Does eating a reheated starchy carbohydrate meal improve postprandial glycaemia?
AbstractIncreased postprandial glycaemia and reduced insulin sensitivity are associated with development of Type 2 Diabetes (T2D). Maintaining a normal glucose response is importan...
Phytochemical Profiling and Mechanistic Investigation of the Antidiabetic Properties of Parquetina Nigrescens
Phytochemical Profiling and Mechanistic Investigation of the Antidiabetic Properties of Parquetina Nigrescens
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder marked by elevated blood glucose levels, primarily caused by insulin resistance and impaired insulin secretion. Desp...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Incretin hormones and type 2 diabetes
Incretin hormones and type 2 diabetes
AbstractIncretin hormones (glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1]) play a role in the pathophysiology of type 2 diabetes. Along with...

